David A. Siegel Ani Pharmaceuticals Inc Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$54.2 - $69.69 $157,180 - $202,101	-2,900 Reduced 17.06%	14,100 $974,000
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $448,224 - $601,956	9,200 Added 117.95%	17,000 $937,000
Q3 2023 Nov 14, 2023	SELL	$50.28 - $64.61 $30,168 - $38,766	-600 Reduced 7.14%	7,800 $452,000
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $123,057 - $177,639	3,300 Added 64.71%	8,400 $452,000
Q1 2023 May 15, 2023	SELL	$37.61 - $45.72 $60,176 - $73,152	-1,600 Reduced 23.88%	5,100 $202,000
Q4 2022 Feb 14, 2023	SELL	$31.9 - $41.95 $382,800 - $503,400	-12,000 Reduced 64.17%	6,700 $269,000
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $1.03 Million - $1.31 Million	-34,500 Reduced 64.85%	18,700 $601,000
Q2 2022 Aug 15, 2022	SELL	$23.09 - $33.46 $745,807 - $1.08 Million	-32,300 Reduced 37.78%	53,200 $1.58 Million
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $34,983 - $61,295	-1,300 Reduced 1.5%	85,500 $2.4 Million
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $1.61 Million - $2.77 Million	48,800 Added 128.42%	86,800 $4 Million
Q3 2021 Nov 15, 2021	SELL	$26.48 - $35.99 $254,208 - $345,504	-9,600 Reduced 20.17%	38,000 $1.25 Million
Q2 2021 Aug 16, 2021	SELL	$31.86 - $38.6 $248,508 - $301,080	-7,800 Reduced 14.08%	47,600 $1.67 Million
Q1 2021 May 17, 2021	SELL	$28.4 - $36.14 $45,440 - $57,824	-1,600 Reduced 2.81%	55,400 $2 Million
Q4 2020 Feb 16, 2021	BUY	$23.69 - $31.47 $35,535 - $47,205	1,500 Added 2.7%	57,000 $1.66 Million
Q3 2020 Nov 16, 2020	BUY	$26.38 - $33.1 $379,872 - $476,640	14,400 Added 35.04%	55,500 $1.57 Million
Q2 2020 Aug 14, 2020	BUY	$29.93 - $50.1 $1.23 Million - $2.06 Million	41,100 New	41,100 $1.33 Million

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account